Figure 5.

Studies assessing the effect of BPA alternatives on oocyte health grouped according to study type and the oocyte health parameter that was assessed within each study. Studies that found an adverse effect in an oocyte health parameter are in orange shaded cells and studies that found no effect are in blue shaded cells. In vivo studies indicated with an asterisk utilized an indirect exposure model, i.e. in utero or breastmilk exposure. Please note that the presence of a study in the blue shaded cells indicates no adverse effect only for the relevant outcome, not the whole study. Many studies may have reported an adverse effect for a different outcome in the figure or, alternatively, a different outcome that was not covered in this review. Studies that were listed as having no adverse effect above but which reported other adverse effects of BPA on the oocyte, ovary or female fertility outside the scope of this review include Nguyen et al. (2022), Sabry et al. (2021a), Vignault et al. (2022), Desmarchais et al. (2022), Nevoral et al. (2018), Nevoral et al. (2021), Prokešová et al. (2020), and Lebachelier de la Riviere et al. (2023). Abbreviations: BHPF, fluorene-9-bisphenol; BPAF, bisphenol AF; BPB, bisphenol B; BPF, bisphenol F; BPS, bisphenol S.